Search
for
Sort by
Research 331–360 of 535
- The role of the skin microbiome in wound healing
- Signaling pathways and targeted therapeutic strategies for polycystic ovary syndrome
- Markers of Venous Thromboembolism Risk in Patients with Alopecia Areata: Is There Anything to Worry about?
- Molecular Mechanisms Affecting Development of Animal Fibers and Some Studies on Goats
- Uso de corticoides no tratamento da Alopecia Areata
- Líquen plano pilar e alopecia frontal fibrosante: correlação dos achados clínicos e dermatoscópicos com o grau de inflamação do exame histopatológico
- Transcriptome Dynamics Reveal Stage-Specific and Melatonin-Triggered Gene Expression Patterns During The Cashmere Growth Cycle in Capra Hircus
- FRI0157 OBSERVATIONAL STUDY OF HAIR FALL IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH LOW DOSE METHOTREXATE COMPARED TO HEALTHY CONTROLS
- 915 Dietary grape powder inhibits atopic dermatitis-like skin lesions in NC/Nga mice
- 918 Skin morphogenesis by coupling biochemical-bioelectric signals: Calcium oscillations coordinate dermal cell movement by epidermis-derived SHH signaling during feather bud orientation
- 916 Gynecologic and hormonal comorbidities of scarring alopecia: A retrospective review
- 1314 Advanced age impairs self-renewal and biases fate choice of hair follicle dermal stem cells
- 1315 An Integrated model of alopecia areata biomarkers highlights both Th1/Th2 upregulation, with stronger correlations between Th2 activation and disease severity
- 1312 Nrf2 activation enhances the healing of cutaneous wounds through the activation of hair follicle stem cells
- 1311 Efficacy of topical tofacitinib in promoting hair growth in non-scarring alopecia
- Medications
- British Society for Dermatopathology
- Review article: dermatological complications of immunosuppressive and anti-TNF therapy in inflammatory bowel disease
- Dermatolojik Problemler ve COVID-19
- ORAL TOFACITINIB IN MODERATE AND SEVERE ALOPECIA AREATA: CASE SERIES OF 14 PATIENTS
- Maintenance, withdrawal, and re-treatment with ritlecitinib and brepocitinib in patients with alopecia areata in a single-blind extension of a phase 2a randomized clinical trial
- Tofacitinib (Selective Janus Kinase Inhibitor 1 and 3): A promising therapy for the treatment of alopecia areata: A case report of six patients
- Clinical response to oral tofacitinib in pediatric patients with alopecia areata
- Therapeutic update on alopecia areata: a critical review of standard and emerging targeted therapies
- P88 Real-world evidence on efficacy and safety of Janus Kinase inhibitors in the treatment of moderate to severe active Ulcerative Colitis
- 705 Particulate matter induces inflammatory response in human outer root sheath cells via oxidative stress-dependent MAPK and JAK-STAT signaling pathways
- Interleukin-15 and Tumor Necrosis Factor-α in Iraqi Patients with Alopecia Areata
- Case Report: Successful Treatment of Alopecia Universalis With Tofacitinib and Increased Cytokine Levels: Normal Therapeutic Reaction or Danger Signal?
- Pharmacologic inhibition of JAK-STAT signaling promotes hair growth
- Targeting the Janus Kinase Family in Autoimmune Skin Diseases